Response to Booster Doses of Hepatitis B Vaccine in Children and Adolescents

Completed

Conditions studied: Hepatitis

In brief

The purpose of this study is to determine the immune response to an additional (booster) dose of hepatitis B vaccine 5-14 years after a three dose series was given

Key facts

Study ID

NCT00141999

Run by

Centers for Disease Control and Prevention

People needed

400

Starts

2001-05-01

Expected to finish

2008-03-01

Last updated by the study team

2012-09-27

Who can join

Age: 5 and older, up to 14. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Received 3 doses of hepatitis B vaccine during infancy, beginning at birth

You may not qualify if…

• Mother HBsAg-positive immunosuppressed

Where it is running

• Alaska Native Medical Center — Anchorage, Alaska, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.